the intensity measurements. Now, exploiting recent progress in high-throughput screening microscopy and computer vision, Wachsmuth et al. 1 have fully automated the entire FC(C)S workflow. This enables for the first time routine FC(C)S measurements in at least 100 single cells per protein of interest, which is what is needed to be able to distinguish the contributions of biological and statistical variation.
To achieve this capability, the group customized the functionality of a high-throughput screening confocal microscope. Using an open-source software called 'Micropilot' , they parameters, including diffusion coefficient, local concentration and states of aggregation. The method can be further extended to fluorescence cross-correlation spectroscopy (FCCS) experiments, which measure co-fluctuation of the fluorescence intensity of differently labeled molecular species, providing information about multimolecular interactions 5 .
Despite its capabilities, FC(C)S has not been widely applied. It is labor intensive and requires subjective decisions to determine when and where to acquire data as well as considerable manual downstream data processing to interpret Understanding of the complex interplay among the thousands of protein species that make up a cell has been constrained by a lack of technologies to measure protein dynamics and interactions. An advance in fluorescence correlation spectroscopy (FCS), described in this issue by Wachsmuth et al. 1 , sets a new standard in the field. The authors present a high-throughput (HT) FCS workflow that allows measurement of the dynamic properties of proteins in thousands of cells and conditions while retaining the ability to investigate specific subcellular locations and specific phases of the cell cycle ( Fig. 1) . This work introduces a powerful approach with a unique ability to measure the behavior of proteins-and potentially other biomolecules-in their natural cellular context in an unbiased, high-throughput manner.
Currently there are two main groups of methods that scientists use to study protein dynamics and interactions. The first group includes approaches such as fluorescence recovery after photobleaching, fluorescence resonance energy transfer and FCS, which are based on imaging fluorescently labeled molecules at high spatial resolution 2 . These methods provide detailed information on the biochemical and biophysical properties of specific proteins in their cellular context, but they are very labor intensive and cannot be applied to more than a handful of proteins or conditions in a reasonable time frame. The second group consists of highthroughput methods, such as mass spectrometry, that can take snapshots of a broad range of proteins 3 but in general have very low spatial and temporal resolution and require averaging over large populations of cells.
Among the microscopy-based methods, FCS is an ideal tool for gaining insight into the dynamic properties of proteins in living cells 4 . FCS measures the fluctuations in photons resulting from fluorescently labeled molecules diffusing in and out of a defined femtoliter-sized observation volume. By recording the fluctuations over time and fitting them with an appropriate correlation function, it is possible to calculate multiple A dynamic picture of protein behavior in cells Wachsmuth et al. 1 applied their method to two specific examples of protein dynamics: the interaction of nuclear proteins with chromatin and the interaction dynamics of cell-cycle proteins through different phases of the cell cycle. In both sets of experiments, the results were consistent with previous findings and identified novel protein interactions to be examined in more detail in future studies.
It should be noted that HT-FC(C)S does not resolve all of the drawbacks of traditional FC(C)S. For example, slow-moving molecular species are still difficult to measure without significant photobleaching effects. In addition, the data must be routinely checked for potential artifacts and systematic errors resulting from non-ideal imaging conditions or imperfect microscope setup. Although HT-FC(C)S fully automates data collection, proteins to be measured have to be fluorescently labeled. Preparing a library of correctly labeled proteins can be challenging as a fluorescent tag may cause protein mislocalization, changes in degradation and other differences in behavior. Finally, given the nature of cross-correlation as a pairwise measurement, extension of the method to protein complexes containing more than two proteins increases analytic complexity substantially.
Despite these limitations, the capacity of HT-FCS to measure protein interaction dynamics in large numbers of single living cells will allow researchers to tackle questions about the cell-to-cell heterogeneity of protein dynamics with sufficient statistical power to distinguish between biological and statistical noise 6 . Pairing HT-FCS with other high-throughput methods such as LC-MS/MS will enable experimental pipelines that can take advantage of large, lowresolution experiments to screen globally for interesting protein interaction candidates and feed them directly into an experimental format that can extract detailed biophysical information. The potential to conduct all these measurements on tagged endogenous proteins (as demonstrated by the authors) by incorporating new genomeediting technologies would also be an exciting avenue to explore in the future. Finally, this method could be combined with more specific chromosomal or other subcellular fluorescent labeling and optogenetic perturbations. We envision HT-FCS developing into a widely used microscopy-based platform to both perturb and measure the biochemical and biophysical properties of endogenous proteins of interest over time with precise spatial and temporal control.
Genetic variation and alternative splicing

Xavier Estivill
The influence of genetic variation on alternative splicing and human disease is modeled in an algorithm that integrates gene expression data.
changes lead to aberrant splicing. The authors validate the predictive performance of the model using RNA-sequencing data from various normal tissues 2 as well as matched genotype and RNA-sequencing data from lymphoblastoid cell lines 3 . They identify >20,000 unique single-nucleotide variants (SNVs) that disrupt splicing and discover previously unknown genes that may be involved in common diseases such as autism (Fig. 1a) . Their method will complement the repertoire of analytic approaches for determining how genetic variants identified by sequencing and genomewide association studies contribute to disease.
As the costs of sequencing continue to fall, whole-genome, exome and targeted sequencing data on thousands of people are becoming available. Analysis of these data has revealed millions of genetic mutations, including SNVs, insertion and deletion variants (indels) and structural variations. But the phenotypic impact of these changes is difficult to assess because many of them are rare or affect only specific cells or tissues.
So far, studies of the effects of genetic variation have emphasized the changes to protein structure and function. Yet we know from parallel genomic and transcriptomic analyses of specific genes that the pathogenicity of mutations may arise through other mechanisms. Variants can also cause disease by altering splicing, the process that determines whether exons are included in mature mRNAs. For instance, most identified mutations (including missense and nonsense mutations) in the neurofibromatosis type 1 gene affect the splicing of its mRNA 4 . In cystic fibrosis, mutations in the introns of the CFTR gene can lead to the inclusion or exclusion of certain exons; some of these mutations are relatively common in certain geographic regions 5 . As these examples suggest, it is important to explore how genetic variants perturb alternative splicing.
Most human genes are spliced, and alternative splicing increases the gene coding capacity of the genome. Understanding the effects of alternative splicing on gene coding is a major challenge in human biology. The role of alternative splicing can be explored at the level of cells, tissues and organs, providing a comprehensive view of the significance of splicing isoforms 6 .
Xiong et al. 1 present a machine-learning approach to evaluate the consequences of singlenucleotide changes on alternative splicing. These changes can be in both coding and noncoding regions and may be up to 300 nucleotides into an intron. The method estimates the percentage of transcripts that contain the spliced exon, which is referred to as PSI or Ψ (ref. 7). Because the RNA sequencing read coverage
